We extensively studied the epidemiology and time course of endemic methicillin-resistant Staphylococcus aureus (MRSA) in the Millard Fillmore Hospital, a 600-bed teaching hospital in Buffalo. The changeover from methicillin-susceptible S. aureus to MRSA begins on the first hospital day, when patients are given cefazolin as presurgical prophylaxis. Under selective antibiotic pressure, colonizing flora change within 24 to 48 hours. For patients remaining hospitalized, subsequent courses of third-generation cephalosporins further select and amplify the colonizing MRSA population. Therefore, managing antibiotic selective pressure might be essential. Other strategies include attention to dosing, so that serum concentrations of drug exceed the minimum inhibitory concentration, and antibiotic cycling. Although there are some promising new antibiotics on the horizon, it is necessary to deal with many resistance patterns by using the combined strategies of infection control and antibiotic management.
tients' anterior nares, resulting in a population of MRSA. The transformation of colonizing MSSA to MRSA occurs very rapidly (i.e., 24 -48 hours) in hospitalized patients [14 -16] . Therefore, both the characteristics of the organism and the onset and time course of subsequent infection argue against crosstransmission as the major initial cause of the emergence of MRSA in hospitals. Furthermore, the very high frequency of this change and the wide variety of different strains that are found make cross-transmission even less likely [16] .
In view of the strong evidence against importation of MRSA and against MRSA cross-transmission [17] , antibiotic selective pressure might play a larger role in the genesis of endemic MRSA than previously suspected. Thus MRSA is not often imported. Rather, it is typically homegrown. The rapid worsening of this problem, despite highly effective infection-control they minimize the chances of importation of MRSA. However, infection control procedures only protect other patients from acquiring MRSA via cross-transmission. Such procedures are
In seeking evidence that better antibiotic management stratedesigned to prevent epidemic spread and are unable to eradicate gies are needed, consider a worst-case scenario. Use of an an endemic population of organisms. In most institutions, antibiotic selects a small multiresistant subpopulation from the MRSA has become endemic rather than epidemic.
MSSA population. The selected organisms survive attack by a patient's WBCs. The patient remains in the same semiprivate room, is attended by the same caregivers, and the other patient The Link Between Outpatient MSSA Colonization, in the room is given the same antibiotic. In the real world, if Inpatient Antibiotics, and MRSA a patient is already receiving an antibiotic active against MSSA All of the major elements of the link between susceptibility but not MRSA, the same antibiotic facilitates cross-transmison the outside, antibiotic-mediated shifts in colonization in sion of this multiresistant organism between patients [27, 28] . hospitals, and subsequent infection were described clearly in McGowan's 1983 review [8] . Although these elements clearly apply to MRSA, it is unfortunate that little was added to the The Rise and Fall of MRSA in Millard Fillmore Hospital basic knowledge about endemic MRSA, in contrast to epidemic MRSA, during the subsequent 14 years. For a time, studies of We have spent considerable time tracking both antibiotic use patterns and the course of MRSA in Millard Fillmore Hosendemic resistance in many organisms were subordinated to excitement over the deluge of new cephalosporin and quinolone pital [29, 30] . As shown in figure 1 , MRSA, which is now polyclonal, appeared at our hospital at about the same time as antibiotics in the mid 1980s. Victory was declared briefly, and drug development ceased. Now, of course, the resistance probit appeared in most of the ú500-bed hospitals reporting to the National Nosocomial Infection Surveillance System. Of lem is back with a vengeance.
In the case of MRSA, there seems little doubt that the antibiparticular interest to us was the fact that the appearance of MRSA coincided with our change from cephalothin prophyotic selection process acting on MSSA begins after patients reach the hospital environment [8, 15, 21] . Patients arrive with laxis to cefazolin prophylaxis, which occurred in 1983 -1984. This temporal pattern was not unique to Millard Fillmore S. aureus as MSSA. The first action that transforms these MSSA to MRSA in hospitalized patients is antibiotic treatment.
Hospital. Throughout the United States, most prophylaxis with cephalosporins changed to that with cefazolin between 1982 The action of antibiotics on the endogenous MSSA selects MRSA from the initially heterogeneous culture [22 -24] . This and 1984 [31] . This almost universal changeover to cefazolin might represent the greatest monopolistic adoption of an antibiselection process can act on a phenotypic MSSA, i.e., one that reads as MSSA on an 18-hour incubation screen for identificaotic regimen of all time. Widespread formulary adoption of cefazolin was driven by marketing efforts, as cephalothin, the tion and susceptibility [23, 25] . In a small subgroup of patients with complications or risk factors, subsequent infections with previously dominant agent, lost its patent protection. In addition, at about this time, the hospital formulary began to play MRSA are likely to occur following colonization with MRSA [17, 26] . a prominent role in the control of antibiotic selection [32] . Even / 9c4c$$my22 04-10-98 02:16:25 cida UC: CID cephalosporin consumption at Millard Fillmore Hospital during the same period [30] . It was this relationship that stimulated our investigation of S. aureus antibiotic resistance in relation to the use of cefazolin, since ú80% of the total cephalosporin use represented in figure 2 was of cefazolin.
Cefazolin and MRSA: The Impact of Antibiotic Exposure on Nasal MSSA
There are reasons to speculate that exposure to cefazolin, a central component of the surgical admission process, exerts a great measure of early selective pressure on MSSA and therefore plays a central role in the origin and endemicity of MRSA A convenient means to evaluate the impact of this in vivo antimicrobial exposure on S. aureus resistance would be to study the impact of exposure to antibiotics on MSSA in the anterior nares, a common reservoir for S. aureus [38] . In a though cephalothin was proven more stable in the presence of case-control study by Kluytmans et al. [13] , nasal carriage of the resistance mechanisms of S. aureus, the formulary commit-S. aureus was found to be a significant risk factor for the tees ascribed greater importance to the pharmacokinetic advandevelopment of sternotomy wound infection following cardiac tage of cefazolin over cephalothin due to three-times-daily dossurgery. Similarly, in clinical trials [39] the risk of sternotomy ing [31, 33] . Cefamandole, despite its greater stability in the infection was found to be four-to-six times higher among papresence of staphylococcal degradation [34 -37] , lost market tients who were nasal carriers of S. aureus. share because of its shorter half-life and higher price per gram.
We used the staphylococcal nasal carriage model for a study As shown in figure 1, Millard Fillmore Hospital's rapidly in healthy volunteers. The results showed that there is an exrising MRSA pattern followed that of a representative 500-bed tremely rapid shift in nasal staphylococcal populations when hospital during the next few years, with an increase in cefazolin cefazolin is used (authors' unpublished observations). In fact, use and an increase in the incidence of MRSA to 40% between it takes õ48 hours to change the nasal colonization profile the years 1983 -1988. Although a similar upward trend in the from that of MSSA carriage to that of MRSA carriage. incidence of MRSA continued at most hospitals, at Millard Serial microbiological studies in surgical patients [16] have Fillmore Hospital the incidence of MRSA declined between also shown that the colonizing MSSA isolates react dramati-1989 and 1991, followed by a return to the previous incidence cally to the antibiotics introduced into their microenvironment. between 1992 and 1994.
During the first 48 hours, cefazolin might either eradicate nasal The decline in the incidence of MRSA at Millard Fillmore MSSA (the outcome for 50% of patients), or the MSSA might Hospital was unusual and was not associated with any apparent be replaced by MRSA because of antibiotic selection (the outchange in infection control personnel, practices, or activities come for Ç15% of patients). In the remaining 35% of patients, at the Hospital. Because we were unable to find an explanation the MSSA persists as MSSA, albeit at a lower inoculum. for this decline in resistance on the basis of our infection control All of these changes occur too rapidly to allow the assumppractices, we searched for an antibiotic-use pattern that mirtion that MRSA has been introduced from the surgical environrored the changes in staphylococcal susceptibility. ment or is the result of a mutation in the original MSSA. Rather, The use of most antibiotics did not correlate temporally with what was thought to be pure MSSA most likely contained a the emergence of MRSA. However, a graph of the use of small subpopulation of mecA-positive S. aureus. Thus, mecA cephalosporins (figure 2) showed the best agreement with the was always present in the MSSA, but initially the numbers of patterns of increasing and decreasing incidences of MRSA dur-MRSA subpopulation isolates were too low to manifest as a ing 1983 -1995. The increase in the incidence of MRSA closely cloudy well after an 18-hour MIC test. Given a longer in vitro followed the increasing use of cephalosporins during the earlyincubation time, we would detect more MRSA than MSSA, a to-mid 1980s. Of even greater interest, the decline in S. aureus resistance in the early 1990s followed a decline in the total well-described [22, 23, 25, 40] but disturbing finding.
/ 9c4c$$my22 04-10-98 02:16:25 cida UC: CID How Resistance Develops in Bacteria and the Role of the but test susceptible to methicillin. In Ç40% of MRSA strains, the mecI is deleted. In the rest of these strains, mecI is present Antibiotics but contains nonsense point mutations. Loss of mecI function, Resistance in hospitals is the product of both bacterial heredwhether as a result of deletion or by mutation, is a necessary ity and bacterial environment. Bacterial environment consists step in the production of PBP2a and expression of methicillin of nutrients and any antibiotic humans introduce. Bacteria are resistance [48] . Although cross-transmission plays a role in the well versed in their survival-oriented task of developing resisspread of MRSA between patients, it seems clear that antibiotic tance to antibacterial substances.
selective pressure on the increasingly heterogeneous MRSA For resistance to develop in any bacteria, a genetic mutation strains, as well as induction of PBP2a production with exposure must occur or the organism must take up a resistance-conferring to b-lactams, are keys to maintaining high-level methicillin plasmid or DNA fragment from the environment. These mutaresistance in hospitals. tions occur in nature, but not at a frequency such that every
The mecA gene, which controls the production of PBP2a, not case of antibiotic resistance is explained by a new mutation.
only confers resistance to b-lactams but also mediates crossThus, the mutations are conserved, which becomes the real resistance to fluoroquinolones, aminoglycosides, tetracyclines, impact of antibiotic therapy. Selective pressure from one or macrolides, and trimethoprim-sulfamethoxazole. The PBP2a-more antibiotics can play a central role because the antibiotics driven altered binding site mechanism is the explanation for the preferentially nurture the mutant strain by eliminating any commost current MRSA problems [25, 49, 50] . A third resistance peting flora that are not already resistant. The more competing mechanism operative in some species of bacteria, permeability organisms that selective antibiotic pressure removes, the better changes, does not appear (at the moment) to be an important it insures the survival and dominance of the selected mutant.
factor in the resistance of S. aureus. Clearly, resistance in hospitals, particularly endemic resistance, Phenotypic expression of methicillin resistance can be either is the result of simultaneous mutation and antibiotic therapy homogeneous or heterogeneous [25, 49, 50] . When this expres- [27, 41] . sion of resistance is homogeneous, all organisms in the culture A typical example of a mutation nurtured by antibiotic therare of identical susceptibility, and they are assumed to be genetapy is the one that selects the b-lactamase genes in Enterobacically identical. Most staphylococci in cultures are heterogeter cloacae. These strains quickly emerge during therapy and, neous [23, 51] . Thus, an entire array of susceptible-to-highly in most cases, become pathogens [42, 43] . Infections and outresistant staphylococcal organisms coexist in the same culture. breaks due to these strains can usually be interrupted or conEven an individual colony of MSSA is heterogeneous, although trolled by removing the nurturing antibiotic -in this case, cefmost individual organisms are susceptible to methicillin at a tazidime [44] . The mutated complex is always present and will low MIC [23, 51] . When there are increasing numbers of organreemerge when the use of ceftazidime is resumed, although isms with increasing resistance (higher MICs), the net effect measures such as using higher doses of ceftazidime along with is expressed as MICs that are above the resistance breakpoint concomitant aminoglycosides might lessen the chances of [51] . This effect was reported as early as 1974 by Sabath emergence of pathogenic E. cloacae in any particular patient.
and Wallace [52] [46] . In addition, production of PBP2a can be antibiotic testing process may be a major reason why MIC changed from constitutive to inducible by the insertion of an testing reveals MRSA at 48 hours of incubation even though inducible penicillinase plasmid [47] . Structural similarities the reading at 18 hours reveals MSSA [23, 25, 54] . There are shared between the mecA gene and the b-lactamase gene make always a few organisms in the inoculum that are resistant to it likely that a repressor gene controls production of PBP2a as the b-lactam agent [22] . Eighteen hours of incubation is not well as production of b-lactamase [46] . MecI and mecRI are long enough for them to grow to predominance, but 48 hours regulator genes located upstream of the chromosomal mecA is clearly sufficient. gene. MecI encodes a repressor of mecA transcription, while Microbiology laboratories will typically report cultured mecRI is a signal transducer with antirepressor activity. A S. aureus as susceptible after 18 hours of incubation, meaning that the oxacillin-containing test-well broth has remained clear. group of clinical staphylococcal strains contain the mecA gene / 9c4c$$my22 04-10-98 02:16:25 cida UC: CID If the culture is incubated for another day, the broth in the ture. Strains susceptible to low MICs have very high AUICs and thus are subject to excellent antibiotic coverage. For strains same well that was read as susceptible to oxacillin on the previous day will be cloudy. The interpretation is that there susceptible to low MICs, the entire dosing interval is spent above the MIC, and thus they are eradicated. Strains susceptible are always small numbers of more-resistant organisms present at the start in a heterogeneous culture [22] . In the wells of the to higher MICs, a small minority of the initial population, are not covered for the entire dosing interval. Therefore, these MIC test, these few organisms require 48 hours of growth in the presence of an antimicrobial exerting selective pressure to strains are selected for survival because they were always resistant. become the predominant heterotype [23] .
Although the mecA gene might be absent, it is also possible With sufficient exposure and absence of host defense, all viable organisms become the progeny of the subpopulations for mecA to be present in small amounts and remain undetected because the detection limit of PCR is above 1,000 bacterial that were not exposed to the antibiotic for sufficiently long periods to effect bacterial killing. Even though the subpopulacells [55, 56] . Small numbers of mecA-containing cells in the MSSA culture population before antibiotic exposure could contions might be present in very small numbers, they are fully capable of becoming the only survivors if antibiotics are given tribute to the higher MIC and yet remain undetected by PCR during the usual genetic analysis [49, 52] . Clearly, both resisand if the host response, i.e., WBCs, does not clear these selected survivors [27, 29, 30, 58, 61] . tance mechanisms are present in some staphylococci, even if these bacteria are phenotypically disguised as MSSA. This
In this scheme, resistance is actually the predictable overgrowth of the surviving organisms that are susceptible to a finding has been noted at least since 1974 [51], although PCR was not available for discerning the molecular mechanism of higher MIC, now the predominant population [27, 54] . They were always present in small numbers; the presence of the the mecA effect until considerably later.
antibiotic enabled them to grow to sufficient numbers that their collective susceptibility is usually higher than the laboratory The Importance of Dosing and Area Under the Curvebreakpoint for susceptibility even though the MIC value would to-MIC Ratio (AUIC) and Why Bacteria for Which the have indicated susceptibility before antibiotic exposure.
Antibiotic MICs are High Become Resistant First
Some examples of the routine occurrence of low AUICs in the patient care setting are provided in table 1. The situations The goal of any antibiotic therapy is to cover (exceed) the MIC of the antibiotic for the infecting pathogen for the entire described in this table are common in most hospitals, and in some cases, in the community as well. The approach to these time between doses. There have been numerous references to antibiotic treatment failure when the concentrations do not exsituations is to track both the antibiotic use and the corresponding bacterial resistance in the indicator pair of isolateceed the MIC [8, 24, 30, [57] [58] [59] [60] [61] . This principle of coverage has been studied in in vitro models [59, 62, 63] ; in animal antibiotic. models of infection [57, 59] ; in healthy volunteers [64, 65] ; and in patients with nosocomial pneumonia [60, 61, 66] , acute If Selection Is So Common, Why Doesn't Every Patient exacerbations of chronic bronchitis [67] , or other infections [68] .
Contract an MRSA Infection? In each of these settings, concentrations that exceed the MIC õ80% of the time are predictive of eradication failure and of Patients who carry nasal MSSA are admitted every day to hospitals everywhere, and the first act of selective pressure in resistance [69] . This principle can be quantitated as the AUIC [58, 65] . Each antibiotic exposure or course of therapy in a many of these hospitals is to give an antibiotic before surgery to prevent postsurgical infection. In many areas of the United patient has a unique AUIC. When the AUIC is below 125, the exposure is õ80% coverage of the MIC for the organism [58, States, the predominantly used antibiotic is cefazolin, and its use begins the process of selection to MRSA. On the basis of 60, 61, 70] .
The striking observation from these studies is the ability of a low AUIC and the presence of a mecA-positive population at baseline, the selective process might be considered a predictthe AUIC to predict resistance as accurately as it predicts bacterial eradication. The typically observed emergence of resistance able pharmacologic effect of the antibiotic, but obviously not all surgical patients contract postsurgical MRSA infections. in the course of treatment for MSSA infection is a mathematically predictable case of selective antibiotic pressure. These Assuming replacement of nasal MSSA by MRSA in Ç15% of patients [21, 39] , one reason that more MRSA infections resistant organisms represent neither new nor unique mutations in the strain of infecting bacteria. Mutations do occur, but not are not observed is the reversion of antibiotic-selected MRSA to heterotypic MSSA. This event follows the cessation of antievery time antibiotics are used. Rather, antibiotic use usually allows a previously mutated subpopulation to emerge. In the biotic therapy. For the majority of patients, cefazolin-mediated selection is obscured by early hospital discharge and the spontacase of resistance in S. aureus, this mechanism was postulated as early as 1961 [71] .
neous reversion of MRSA to MSSA. The normal time required for nasal MRSA to revert to the usual nasal MSSA is Ç30 In essence, the coverage described as an AUIC ú125 is different for each subpopulation of organisms within the culdays [38] .
/ 9c4c$$my22 04-10-98 02:16:25 cida UC: CID Clearly, if a surgical patient is discharged from the hospital The full time course of the selective pressure process is described in figure 3 . Cefazolin is the likely source of the initial after 3 -4 days and is not given additional antibiotics, the entire process of reversion of the initial MSSA colonies to MRSA population heterogeneity, but antibiotic selective pressure continues in those subsets of patients who remain in the hospital colonies and back again to MSSA colonies will occur, but it will be undetected in otherwise asymptomatic outpatients. A for a longer time. As shown in figure 3 , the constitution of this heterogeneous MSSA/BSSA (''borderline'' susceptible S. change in colonizing flora would be noticed if cultures were performed, but cultures are rarely performed for postsurgical aureus)/MRSA organism is further altered with exposure to third-generation cephalosporins. Eventually only MRSA, with patients solely to assess their MRSA carrier status, let alone to periodically monitor susceptibility changes in colonizing its high-level resistance to cephalosporins, survives the continual selective pressure. These strains primarily colonize patients flora. Because length-of-stay for surgical patients continues to become shorter, early hospital discharge without residual use who have been in the hospital for 1 -2 weeks. Many of these patients are subsequently transferred back to intensive care of antibiotics is a temporary protective strategy used in many communities, as it has been in Buffalo. Selective antibiotic units as MRSA carriers [26] . The final steps in the continuum are vancomycin use and the selection of vancomycin-resistant pressure can sustain MRSA in any environment; therefore, moving patients out of the hospital and sending them home Enterococcus faecium in a proportion of patients, as shown in figure 3 . with cephalosporins will sustain MRSA in outpatient populations. This practice must be discouraged.
The MRSA pool of a hospital further expands when MRSA carriers are admitted from the community or from nursing homes. In such situations, lapses in infection control procedures play an increasingly important role.
The Controversy over Cefazolin Prophylaxis for Surgery
Resistance will occur more readily during the course of antibiotic therapy in patients infected with S. aureus for which the baseline antibiotic MIC approaches the laboratory breakpoint for resistance. Many investigators have noted that the MICs of the penicillinase-resistant penicillins, such as oxacillin, do not change during therapy as readily as the MICs of cephalosporins [34 -36, 52] . This phenomenon, which is typical of MSSA for which the cefazolin MIC breakpoint is 4.0 -8.0 mg/mL [24, other hand, there are also animal models [72 -74] and studies days, assuming all clinical events take place as described in the text.
of antibiotic prophylaxis in surgery [75 -77] that have shown For 90% of admitted patients, discharge occurs in 2 days, and the clinical differences among the cephalosporins in the same rank remainder have complicated courses and remain hospitalized for 21 order that would be predicted only on the basis of in vitro tests days. The typical antibiotic use patterns among the inpatients are the administration of ceftazidime on day 5 and vancomycin on day 8, after [34, 35, 78, 79] .
cultures on day 7 yield methicillin-resistant Staphylococcus aureus Strongly documented arguments have been made against (MRSA) . This is a temporal study of selective pressure on staphylousing cefazolin and in favor of using more stable cephalospococci, resulting from cephalosporin use, and then on Enterococcus rins such as cefamandole, cephalothin, and perhaps, cefuroxime faecium, resulting from vancomycin use. BSSA Å ''borderline'' sus- [24, 34, 73 -77] . The use of cefazolin has been defended in ceptible S. aureus; MSSA Å methicillin-susceptible S. aureus; VREF Å vancomycin-resistant E. faecium.
studies of animal models [72] and of antibiotic prophylaxis in / 9c4c$$my22 04-10-98 02:16:25 cida UC: CID surgerical patients [80] . The authors of the favorable cefazolin 1. Prophylaxis accounts for the largest volume of cefazolin use in most hospitals, and it appears that prophylaxis is studies have been criticized for using doses of the competing newer cephalosporins that were too low [81] . There actually the usual situation in which cefazolin AUIC values are routinely below 125 for MSSA. is considerable evidence [82] of the importance of dosing regimens and timing for all the cephalosporins with a short half-2. Prophylactic use affords the first opportunity for many patients entering the hospital to be treated with an antibilife.
Routine prophylactic use of the most labile of the cephalootic regimen that may result in selective pressure -mediated resistance, potentially expressing the inherent MRSA sporins, cefazolin, is further compromised by lowering its dosage to 1.0 g every 8 hours. The impact of the resulting underexin a majority of MSSA carriers. 3. Even if cefazolin is not the selecting agent for all MRSA, posure is readily appreciated by comparing the drug's pharmacokinetics [33] with its MIC. Figure 3 shows the serum it is generally easier to alter regimens containing this antibiotic because prophylaxis guidelines are under better cefazolin concentrations during a typical prophylactic regimen of 1 g every 8 hours. The calculated AUIC for cefazolin at control in most hospitals than are empirical regimens. 4. Strictly on the basis of volume of use, which approaches this dosage does not comfortably exceed 125 when the MIC for the MSSA present at baseline is 4 -8 mg/mL. Furthermore, 80% of all cephalosporin use, cefazolin use is an attractive target for interventions designed to target resistance. Tarthese AUICs are based on the total concentration of cefazolin (free and protein bound). The free concentrations of cefazolin geting monopolistic use first makes sense in a world in which hospitals are understaffed and the staffs are overare õ10% of the values shown in figure 3 .
How often does this occur? Even in the early-to-mid 1980s, worked. it appeared to occur quite frequently in hospitals with MSSA and perhaps a few BSSA isolates [24] . Furthermore, the heterotypic nature of MRSA guarantees that there are selectable subWhy Is the Emergence of Vancomycin-Resistant populations in most colonized, cefazolin-treated patients. What, Enterococcus faecium the Next Step in the Chain of then, were the consequences? After cardiothoracic surgery, cefEvents? azolin-treated patients had more infections than did cefamandole-treated patients [24, 75 -78] .
Clearly, selective antibiotic pressure due to the use of At that time, there was good reason to link resistance develcephalosporins is a plausible explanation for the transformaopment to the BSSA variant of MSSA. Now that many apparent tion of MSSA to MRSA and the associated endemic status MSSA strains carry the mecA gene and synthesize b-lactamase of this organism in United States hospitals. Perhaps less [83] , it is even more important to consider borderline susceptiapparent are the links between the use of cephalosporins and bility of MSSA. For patients infected with these strains, the MRSA and the use of vancomycin and vancomycin-resistant poor outcomes of prophylaxis are predictable from the relationEnterococcus faecium (VREF), the process diagramed in ships between cefazolin serum concentrations and the MICs figure 3 . If all of these links stand the test of time, then for the S. aureus populations ( figure 3) .
the VREF epidemic might also be directly linked to use of Thus the studies done ú10 years ago by Sabath et al. [34, cephalosporins, investigators observed a clear decline in the incidence of [35] are now being viewed as prophetic. Unfortunately, because VREF in relation to reductions in the use of third-generation of cefazolin's longer half-life [31, 33] and other desirable charcephalosporins and the associated replacements by the comacteristics such as its lower price, it became the predominant bination of a penicillin with a b-lactamase inhibitor. If the antibiotic used as prophylaxis before surgery. Cefazolin has use of cephalosporins selects for MRSA, then the solution remained the drug of choice over the past 15 years. However, to the current VREF epidemic could be closely tied to the this long run of monopolistic use might be nearing an end.
solution to the MRSA problem. After all, MRSA drives the Cefazolin achieved its status because of its pharmacokinetic use of vancomycin. characteristics. Unfortunately, it has poor stability in the presRestriction of vancomycin use at the Millard Fillmore ence of the current version of S. aureus, now a mutated organHospital might be considered a direct attack on the specific ism that both synthesizes b-lactamase and possesses mecA to problem. We already had effective infection control meafacilitate its survival. Furthermore, it doesn't help when the sures, as indicated by the fact that VREF was not transmitted cefazolin dose is continually lowered in an effort to save from patient to patient. In our institution, the emergence of money.
VREF was associated with the use of oral vancomycin, so If first-generation cephalosporins can be linked to selective restriction of oral vancomycin use alone was an effective pressure -mediated resistance, part of the solution could be countermeasure. The absence of a transplant population, better antibiotic management strategies. Prophylactic use is a which represents a second epidemiologic pattern (a patient logical topic with which to begin a new focus on antibiotic population less responsive to the strategy of restricting the use of oral vancomycin), allowed this simple strategy to management, for several reasons: Each institution is different, as are the strategies that might need to be applied to its own resistance problems. For some institutions, but perhaps a minority in this modern era, the solutions to endemic resistance lie in better infection control restricting the new antibiotics believed to be inappropriately used [32] .
The second change made in the late 1980s was loosely work better at our hospital than it might at hospitals with termed ''the reductionist strategy,'' which consisted of lowboth epidemiologic patterns.
ering dosages and prolonging dosage intervals for most new In addition to our experiences, the results of Wright et al.
antibiotics [88, 89] . After ceftriaxone reached the market, the [86] , who conducted a study in a university hospital, support manufacturers of every competing antibiotic, no matter how the association between the emergence of VREF and vancomyquickly excreted, argued that clinicians prolong its dosing intercin use patterns. In that study, VREF was related more to the val to once or twice daily, with a resultant decrease in many use of iv drug than to the use of oral drug. Use of oral vancomy-AUIC values to õ125. For a time, less money was spent on cin was restricted hospitalwide, but the associated strategy was some of these antibiotics. However, the price was more therato restrict the use of iv vancomycin in one of the two intensive peutic failures in some cases, and eventually more total antibicare units. It is not surprising that a decline in the incidence otic expense as resistance drove empirical use toward the most of VREF was observed in the intensive care unit where the expensive, newer broad-spectrum agents. use of iv vancomycin was restricted, while there was no change There is no evidence that the formulary system was a marketin the unit where the use of iv vancomycin was not restricted.
ing ploy to increase use of the newest antibiotics because of If the incidence of VREF had declined in both units, then a the emergence of resistance, even though that is exactly what link between VREF and hospitalwide restriction of the use of happened. However, the ensuing years have taught us that oral vancomycin might be the explanation. Wright et al. clearly formularies do not control the upward trend in the total antibiidentified the VREF that was linked to the use of iv vancomyotic expenditures of a hospital; they merely select which antibicin, typical of an endemic pattern in intensive care units.
otic will be used most, and therefore, cost most [28] . FurtherWhether an institution in this position needs to restrict the use more, the tendency to use only one antibiotic results in a of oral vancomycin is debatable, but it seems prudent to do so selective pressure that is highly advantageous to the bacterial on the basis of the Centers for Disease Control and Prevention pathogens intrinsically or genetically equipped to overcome its guidelines [87] .
effects. In addition, antibiotic formularies do not save money, Thus a strategy to eradicate MRSA, such as replacement of as recently shown in a survey of more than 100 hospitals [90] . cefazolin with cephalothin or another more stable antibiotic for Finally, the resulting pattern of monopolistic antibiotic use prophylactic use, could lower the frequency with which MSSA might have fostered the greatest resistance outbreak in the hisbecomes MRSA. In turn, the lower frequency of MRSA will tory of modern antibiotic management [27] . We are now result in less use of vancomycin; with less vancomycin-related quickly running out of effective antibiotics, and we find ourselective pressure, the incidence of VREF will decline in the transplant population. This combined strategy, designed to selves desperately searching for a strategy to restore the activity / 9c4c$$my22 04-10-98 02:16:25 cida UC: CID of the ones we have. That strategy could be to quickly reverse agents must also be used as part of a coordinated antiresistance strategy. We will not succeed either with monopolistic use or what we did to cause our current problems.
First, to reverse the rapidly accelerating resistance pandemic, with nonuse of these new agents. They must be used to solve some of our resistance problems, meaning that they might have formularies need once again to be opened up to include various agents in order to lessen the selective advantages afforded roles in cycling regimens, switch programs, and the treatment of infections due to specific pathogens. The lessons of history certain bacteria. Second, the empirical use of antibiotics should be alternated among classes rather than within classes (e.g.,
need to be applied if we are to integrate the new agents into the overall antibiotic armamentarium. from cephalosporins to quinolones rather than from cephalosporin to cephalosporin) [91, 92] . Alternating the pattern of use should be applied more randomly and should be less driven by the rigidity of a closely controlled formulary. Third, in some these new agents promises treatment alternatives, but these / 9c4c$$my22 04-10-98 02:16:25 cida UC: CID
